The opioid overdose treatment market focuses on providing treatment against drug overdose caused due to abuse of prescription and illicit opioids. Opioids are a class of drugs that include prescription pain relievers such as morphine, codeine, oxycodone, hydrocodone, fentanyl, and methadone. The recent surge in opioid abuse has significantly increased cases of opioid overdose, creating an urgent need for effective treatment options. Some of the commonly used treatments for opioid overdose include naloxone, buprenorphine, and methadone. Naloxone is considered the first line of treatment as it can reverse the effects of opioid overdose when given in time.



The Global Opioid Overdose Treatment Market is estimated to be valued at US$ 1,428.5 million in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031.



Key Takeaways

Key players operating in the opioid overdose treatment are Addex Therapeutics, AstraZeneca, Emergent BioSolutions, IntelliPharmaCeutics, Narx Care, Hikma Pharmaceuticals, Pfizer, and US WorldMeds.



The growing abuse of prescription and illicit opioids is a major factor driving the demand for opioid overdose treatment. According to the National Institute on Drug Abuse, opioid overdose deaths in the U.S. increased almost 4 times between 1999 and 2018. This widespread opioid crisis has necessitated the development of more effective and affordable treatment options.



Leading pharmaceutical manufacturers are focusing on expanding their presence globally, especially in developing regions of Asia Pacific and Latin America that are witnessing a rapid surge in opioid abuse. Partnerships with local healthcare providers and governments are helping increase accessibility of overdose treatments.



Market Drivers

Increasing funding for addiction treatment programs is a key driver for the opioid overdose treatment market. Governments across various countries have significantly ramped up funding to make treatments more affordable and expand coverage through public health programs. This improved access to healthcare is facilitating the adoption of overdose treatments among addicts. Moreover, rising awareness about opioid abuse risks and availability of antidotes like naloxone is supporting the market growth.



With the current geopolitical situation, the opioid overdose treatment market is facing many challenges globally. The ongoing Russia-Ukraine conflict has strained ties between many nations and disrupted worldwide supply chains. This has impacted the availability of key drugs and medical devices required for opioid overdose treatment. Manufacturers are facing shortages of raw materials and face difficulties in transporting finished products across borders timely.



The United States accounts for over 40% of the global market value currently. However, the ongoing trade tensions and political disagreements between the US and other major economies like China and the European Union has made companies wary of over-reliance on any single market. Diversifying manufacturing and distribution networks across multiple regions has become a priority to hedge risks. Furthermore, issues like lack of universal healthcare in the US puts financial pressure on patients, hindering the market growth potential.



The Asia Pacific region excluding Japan is projected to witness the fastest growth during the forecast period. Countries like China, India, South Korea, and Australia are expected to see rising prevalence of opioid abuse and overdose cases. This is driven by factors such as increasing consumption of prescription opioids, easy availability of illicit drugs, and lack of social awareness on risks of substance misuse. At the same time, these nations are dedicating greater healthcare budgets to expand treatment infrastructure and access to care. This makes the APAC region an attractive investment location for opioid overdose treatment manufacturers.



Europe currently holds the second largest share in the market worth, led by countries like Germany, United Kingdom, France, and Italy. However, ongoing issues like Brexit uncertainty in the UK, rise of nationalist sentiments, and economic challenges arising from the Russia-Ukraine conflict have added an element of instability to business outlook within Europe. Companies must closely monitor regulatory and trade policy changes while balancing supply networks within the region to mitigate risks.

Get more insights on this topic : https://www.patreon.com/posts/opioid-overdose-118754621

What Are The Key Data Covered In This Opioid Overdose Treatment Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Opioid Overdose Treatment's growth between 2024 and 2031.

:- Accurate calculation of the size of the Opioid Overdose Treatment and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Opioid Overdose Treatment Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Opioid Overdose Treatment vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:

1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it